Adverum Biotechnologies, Inc.
ADVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,652 | -$49,191 | -$47,019 | -$40,931 |
| Dep. & Amort. | $465 | $535 | $683 | $810 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,349 | $2,423 | $2,778 | $0 |
| Change in WC | $16,647 | $7,490 | $215 | $8,932 |
| Other Non-Cash | $76 | -$24 | $572 | $2,940 |
| Operating Cash Flow | -$28,115 | -$38,767 | -$42,771 | -$28,249 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$142 | -$120 | -$220 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$1,976 | $0 | -$19,128 |
| Inv. Sales/Matur. | $2,000 | $34,000 | $31,500 | $15,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $1,858 | $31,904 | $31,280 | -$4,189 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,899 | $120 | $0 | $239 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9,899 | $120 | $0 | $239 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$16,358 | -$6,743 | -$11,491 | -$32,199 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44,394 | $51,137 | $62,628 | $92,851 |
| End Cash | $28,036 | $44,394 | $51,137 | $60,652 |
| Free Cash Flow | -$28,257 | -$38,887 | -$42,991 | -$28,310 |